[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335910-105":59,"doc-detail-335910-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","spatial-architectures-of-somatic-mutations-in-normal-prostate-benign-prostatic-hyperplasia-and-coexisting-prostate-cancer","Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer","","This study aimed to identify somatic mutations in nontumor cells (NSMs) in normal prostate and benign prostatic hyperplasia (BPH) and determine how those changes relate to prostate cancer (PCA). Whole-genome sequencing was performed on 3D-mapped samples from 50 normal, 46 BPH, and 1 PCA case tissue, including trio-sampled prostates. Although normal and BPH tissues shared low-incidence driver NSMs and CNAs, BPH showed higher mutation burden, shorter telomere length, larger clone size, and more private NSMs. NSM patterns revealed peripheral-zonal dominance and right-side asymmetry with heterogeneous sample differences, and early embryonic mutations formed layered and mixed distributions. The BPH genome was closer to normal prostate than to PCA, suggesting links to aging or environmental stress rather than tumorigenic processes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/spatial-architectures-of-somatic-mutations-in-normal-prostate-benign-prostatic-hyperplasia-and-coexisting-prostate-cancer/335910/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/spatial-architectures-of-somatic-mutations-in-normal-prostate-benign-prostatic-hyperplasia-and-coexisting-prostate-cancer/335910.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the study investigate about somatic mutations in the prostate?","Question",{"text":113,"@type":114},"The study examines somatic mutations in nontumor cells within normal prostate and BPH and evaluates how those mutations relate to coexisting prostate cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were NSMs detected and spatially analyzed in this research?",{"text":118,"@type":114},"The authors used a hybrid design comparing whole-genome sequencing results from serial microdissections across multiple prostate areas, enabling large-area analysis with 3D sampling and trio sampling.",{"name":120,"@type":111,"acceptedAnswer":121},"What key differences were found between BPH and normal prostate genomes?",{"text":122,"@type":114},"BPH samples showed a higher mutation burden, shorter telomere length, larger clone size, and more private NSMs, even though both tissues shared several driver NSMs and CNAs at low incidence.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335910,1790020110,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","[www.nature.com/emm](www.nature.com/emm)  \nARTICLE OPEN  \nSpatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer  \nJeesoo Chae1,2, Seung-Hyun Jung 3,4,5, Eun Ji Choi6, Jae Woong Kim5,6, Na Yung Kim5, Sung Won Moon5,6, Ji Youl Lee7, Yeun-Jun Chung 1,4,5,8 ✉ and Sug Hyung Lee1,5,6 ✉  \n© The Author(s) 2023  \n\n|  | This study aimed to identify somatic mutations in nontumor cells (NSMs) in normal prostate and benign prostatic hyperplasia (BPH) and to determine their relatedness to prostate cancer (PCA) . From 22 PCA patients, two prostates were sampled for 3-dimensional mapping (50 normal, 46 BPH and 1 PCA samples), and 20 prostates were trio-sampled (two normal or BPH samples and one PCA sample) and analyzed by whole-genome sequencing. Normal and BPH tissues harbored several driver NSMs and copy number alterations (CNAs), including in FOXA1, but the variations exhibited low incidence, rare recurrence, and rare overlap with PCAs. CNAs, structural variants, and mutation signatures were similar between normal and BPH samples, while BPHs harbored a higher mutation burden, shorter telomere length, larger clone size, and more private NSMs than normal prostates. We identiﬁed peripheral-zonal dominance and right-side asymmetry in NSMs, but the asymmetry was heterogeneous between samples. In one normal prostate, private oncogenic RAS-signaling NSMs were detected, suggesting convergence in clonal maintenance. Early embryonic mutations exhibited two distinct distributions, characterized as layered and mixed patterns. Our study identiﬁed that the BPH genome differed from the normal prostate genome but was still closer to the normal genome than to the PCA genome, |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| suggesting that BPH might be more related to aging or environmental stress than to tumorigenic processes. |  |  |\n|  | Experimental & Molecular Medicine (2024) 56:168–176; [https://doi.org/10.1038/s12276-023-01](https://doi.org/10.1038/s12276-023-01)140-8 |  |\n|  |  |  |\n\nINTRODUCTION  \nAs opposed to the earlier concept that nontumor cells do not harbor somatic mutations, somatic mutations in nontumor cells (NSMs) are known to occur in whole-body organs1–3. To date, research has shown that (i) the NSM prevalence is different depending on the organ; (ii) NSM number and clone size increase with age, inﬂammation, and mutagen exposure; (iii) although most NSMs are not cancer drivers, over 140 somatic driver NSMs have been identiﬁed across organs; (iv) mutation signatures of NSMs are commonly related to aging, but other signatures have been reported; and (iv) the causal relationship between NSMs and cancer risk remains uncharacterized 1,4–7. NSMs include early embryonic mutations (EEMs) that accumulate throughout life after the ﬁrst cell division2,8–12. An earlier study showed that prostate NSMs accumulated over a lifetime with two large waves during embryogenesis and puberty and were enriched in peripheral areas compared to periurethral areas13. However, somatic drivers, rearrangements, and copy number alterations (CNAs) among prostate NSMs are rare13. Even with this discovery, the NSMs of benign prostatic hyperplasia (BPH) and their relatedness to prostate cancer (PCA) have not been studied. Since NSMs in nonneoplastic diseases are common in other organs (both pro- and anti-disease development)5, 14–16, simultaneous  \nanalysis of normal and BPH NSMs is essential to understand normal prostate progression to BPH or PCA.  \nDetection methods for NSMs vary depending on the study’s purposes. Whole-genome sequencing (WGS) of single-cell derived cultures allows NSM detection in single genomes but does not provide spatial information in the tissue or speciﬁc nonneoplastic states such as BPH8. Laser-capture microdissection provides NSMs with spatial information but can analyze a limited number of","cbCaigF1VPjMTFVE","https://ap.wps.com/l/cbCaigF1VPjMTFVE","pdf",2193089,"English","# Introduction\n## Study aim and rationale\n## Detection methods for NSMs\n## Study design and research questions","[{\"question\":\"What does the study investigate about somatic mutations in the prostate?\",\"answer\":\"The study examines somatic mutations in nontumor cells within normal prostate and BPH and evaluates how those mutations relate to coexisting prostate cancer.\"},{\"question\":\"How were NSMs detected and spatially analyzed in this research?\",\"answer\":\"The authors used a hybrid design comparing whole-genome sequencing results from serial microdissections across multiple prostate areas, enabling large-area analysis with 3D sampling and trio sampling.\"},{\"question\":\"What key differences were found between BPH and normal prostate genomes?\",\"answer\":\"BPH samples showed a higher mutation burden, shorter telomere length, larger clone size, and more private NSMs, even though both tissues shared several driver NSMs and CNAs at low incidence.\"}]","Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer | PDF",1790012808,23]